Literature DB >> 3436740

In vitro antitumor effect of recombinant human tumor necrotizing factor on cultured human cancer cell lines and freshly isolated lung cancer cells by the human tumor clonogenic assay.

Y Sasaki1, F Kanzawa, H Takahashi, Y Matsushima, H Nakano, K Nakagawa, W S Hong, K Minato, Y Fujiwara, N Saijo.   

Abstract

In vitro antitumor effects of human recombinant tumor necrotizing factor (rH-TNF) were examined against nine lung cancer cell lines including six non small and three small cell lung cancer, four stomach cancer cell lines and 30 freshly isolated lung cancer cell samples by the human tumor clonogenic assay. rH-TNF did not show any inhibitory effect on the colony formations of lung and stomach cancer cell lines, except for PC10 established from squamous cell carcinoma even at the high concentration. The overall response rate of fresh material was 11.5%. The colony formations of only two materials from 20 patients without prior chemotherapy were significantly suppressed by rH-TNF in vitro. Three specimens of adenocarcinoma exhibited more than 70% decrease in colony number by treating with 100 and 1000 u/ml of rH-TNF resulting in the response rate of 15.8% (3/19). From these results, it can be concluded that rH-TNF has modest direct cytotoxic effect on lung cancer, and additional study against adenocarcinoma of the lung might be warranted.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436740     DOI: 10.1007/BF00169974

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  18 in total

1.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

2.  Applications of the human tumor stem cell assay to new drug evaluation and screening.

Authors:  S E Salmon
Journal:  Prog Clin Biol Res       Date:  1980

3.  Tumor necrosis factor (TNF).

Authors:  L J Old
Journal:  Science       Date:  1985-11-08       Impact factor: 47.728

4.  Human tumor colony assay and chemosensitivity testing.

Authors:  S E Salmon
Journal:  Cancer Treat Rep       Date:  1984-01

5.  A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

Authors:  J C Ruckdeschel; D M Finkelstein; D S Ettinger; R H Creech; B A Mason; R A Joss; S Vogl
Journal:  J Clin Oncol       Date:  1986-01       Impact factor: 44.544

6.  The use of human cancer cell lines as a primary screening system for antineoplastic compounds.

Authors:  G J Finlay; B C Baguley
Journal:  Eur J Cancer Clin Oncol       Date:  1984-07

7.  Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay.

Authors:  Y C Lee; N Saijo; Y Sasaki; H Takahashi; M Sakurai; J Ishihara; A Hoshi; K M Chen; A W Hamburger
Journal:  Jpn J Clin Oncol       Date:  1985-12       Impact factor: 3.019

8.  Application of a human tumor colony-forming assay to new drug screening.

Authors:  R H Shoemaker; M K Wolpert-DeFilippes; D H Kern; M M Lieber; R W Makuch; N R Melnick; W T Miller; S E Salmon; R M Simon; J M Venditti
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

9.  Prospective clinical trial of a human tumor cloning system.

Authors:  D D Von Hoff; G M Clark; B J Stogdill; M F Sarosdy; M T O'Brien; J T Casper; D E Mattox; C P Page; A B Cruz; J F Sandbach
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

10.  Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.

Authors:  T Shinkai; N Saijo; K Tominaga; K Eguchi; E Shimizu; Y Sasaki; J Fujita; H Futami
Journal:  Cancer Treat Rep       Date:  1985-09
View more
  3 in total

1.  Antitumor immune surveillance by tumor necrosis factor producing cells.

Authors:  E C Lattime; O Stutman
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Growth-inhibiting effect of intratumoral recombinant human tumor necrosis factor on an experimental model of primitive neuroectodermal tumor.

Authors:  J Vaquero; M Zurita; S Oya
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  Enhancement of cytotoxicity of cisplatin in vitro by recombinant human tumor necrosis factor and/or recombinant human interferon-alpha, -beta and -gamma.

Authors:  C M Kim; W S Hong; J O Lee; T W Kang; Y W Kim; J K Song; T K Yun; C Y Kim
Journal:  Jpn J Cancer Res       Date:  1989-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.